Glaxosmithkline (GSK)

 

Latest News

Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLC

Liberum Capital today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target t...

Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLC

Barclays Capital today upgrades its investment rating on GlaxoSmithKline PLC (LON:GSK) to overweight (from equal we...

Director/PDMR Shareholding

RNS Number: 0616C GlaxoSmithKline PLC 16 January 2018 GlaxoSmithKline plc (the ' Company ') Transaction notification 1. Details of PDMR/person closely associated with them ('PCA') a) Name Ms E Walmsley b) Position/status Chief Executive Officer c) Initial notification/ amendment Initial notification 2. Details of the issuer, emission allowance market participa...

Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLC

Jefferies International today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and set its price tar...

All News

DateHeadlineSource
18-01-18Broker Forecast - Liberum Capital issues a broker note on GlaxoSmithKline PLCStockMarketWire
17-01-18Broker Forecast - Barclays Capital issues a broker note on GlaxoSmithKline PLCStockMarketWire
16-01-18Director/PDMR ShareholdingRNS
16-01-18Broker Forecast - Jefferies International issues a broker note on GlaxoSmithKline PLCStockMarketWire
16-01-18Broker Forecast - Exane BNP Paribas issues a broker note on GlaxoSmithKline PLCStockMarketWire
15-01-18Director/PDMR ShareholdingRNS
15-01-18Director/PDMR ShareholdingRNS
15-01-18Director/PDMR ShareholdingRNS
15-01-18Director/PDMR ShareholdingRNS
15-01-18Director/PDMR ShareholdingRNS
11-01-18Director/PDMR ShareholdingRNS
11-01-18Broker Forecast - Deutsche Bank issues a broker note on GlaxoSmithKline PLCStockMarketWire
02-01-18Director ShareholdingRNS
02-01-18Total Voting RightsRNS
21-12-17GSK gets US approval to remove boxed warning StockMarketWire
21-12-17FDA approval - on ICS/LABA combinations in asthmaRNS
18-12-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
18-12-17Director/PDMR ShareholdingRNS
15-12-17GlaxoSmithKline transfers shares from treasury StockMarketWire
15-12-17Transfer of Shares out of TreasuryRNS
13-12-17Broker Forecast - Citigroup issues a broker note on GlaxoSmithKline PLCStockMarketWire
12-12-17Director/PDMR ShareholdingRNS
12-12-17GSK gains US approval for Nucala to treat EGPARNS
12-12-17GSK presents promising new data at ASHStockMarketWire
12-12-17Promising data for GSK2857916 at ASH meetingRNS
06-12-17New data supports efficacy of Shingrix, says GSKStockMarketWire
06-12-17New data - Shingrix in immune-compromised patientsRNS
05-12-17Best dividend yields and 10 'buy' ideasInteractive Investor
04-12-17Chart of the week: A FTSE 100 bank tradeInteractive Investor
01-12-17These five AIM firms could own the tech stars of tomorrowInteractive Investor
01-12-17Director Deals - GlaxoSmithKline PLC (GSK)StockMarketWire
01-12-17Director/PDMR ShareholdingRNS
01-12-17Director/PDMR ShareholdingRNS
01-12-17Total Voting RightsRNS
01-12-17Broker Forecast - Morgan Stanley issues a broker note on GlaxoSmithKline PLCStockMarketWire
30-11-17ViiV starts phase 3 HIV prevention study in womenStockMarketWire
30-11-17ViiV starts Phase 3 HIV prevention study in womenRNS
27-11-17FTSE falls as copper price declinesStockMarketWire
27-11-17ViiV starts Phase 3 longacting HIV treatment studyRNS
27-11-17Chart of the week: A low-risk blue-chip 'buy'Interactive Investor

RSS feeds

  • Editorial news feed for LSE:GSK Editorial
  • Regulatory news feed for LSE:GSK Regulatory

Join interactive investor

  • £22.50 fixed quarterly charge includes £22.50 in trading credits
  • £10 per trade or £6 for frequent traders
  • No % platform fees
  • £1 per trade for regular investment or dividend reinvestment

Open an account